Abbott Laboratories (NYSE:ABT)
| 86.35 Delayed Data As of Dec 13 |  +0.38 / +0.44%Today’s Change | 65.44 Today|||52-Week Range 88.76 | +19.38% Year-to-Date |
Latest ABT News | Press Releases
| Is Abbott Laboratories Stock a Buy? Dec 08 / MotleyFool.com - Paid Partner Content | Despite the Naysayers, AbbVie Keeps Marching On Dec 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 85.97 |
| Today’s open | 85.78 |
| Day’s range | 85.78 - 86.71 |
| Volume | 3,872,210 |
| Average volume (3 months) | 4,507,948 |
| Market cap | $152.8B |
Data as of 6:30pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | +397.55% |
| Earnings growth (this year) | +12.59% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +11.64% |
| P/E ratio | 46.9 |
| Price/Sales | 4.19 |
| Price/Book | 4.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | +3.28 | +1.24% |
| BSXBoston Scientific Co... | +0.42 | +0.94% |
| BAXBaxter International... | +0.45 | +0.54% |
| ZBHZimmer Biomet Holdin... | +0.66 | +0.45% |
Data as of 6:30pm ET, 12/13/2019
Financials
| Next reporting date | January 24, 2020 |
| EPS forecast (this quarter) | $0.95 |
| Annual revenue (last year) | $30.6B |
| Annual profit (last year) | $2.4B |
| Net profit margin | 7.58% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
